Association Between Blunted Glomerular Hyperfiltration in Pregnancy and Severe Maternal Morbidity-A Research Letter

被引:0
|
作者
Harel, Ziv [1 ,2 ]
Park, Alison L. [2 ]
Ray, Joel G. [2 ,3 ,4 ]
机构
[1] St Michaels Hosp, Div Nephrol, 61 Queen St,Suite 730, Toronto, ON M5C 2T2, Canada
[2] ICES, Toronto, ON, Canada
[3] St Michaels Hosp, Dept Med, Toronto, ON, Canada
[4] St Michaels Hosp, Dept Obstet & Gynaecol, Toronto, ON, Canada
关键词
glomerular hyperfiltration; pregnancy; severe maternal morbidity;
D O I
10.1177/20543581211035221
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Glomerular hyperfiltration is one physiological adaptation to pregnancy, marked by a decline in serum creatinine (SCr) concentration by 16 weeks' gestation. It is not known whether blunted glomerular hyperfiltration leads to adverse maternal outcomes, including severe maternal morbidity (SMM). Objective: To evaluate the association between blunted glomerular hyperfiltration and subsequent SMM or death. Design: Population-based cohort study Setting: Ontario, Canada, from 2008 to 2019. Participants: Included were births among women who had >= 1 SCr measured as an outpatient within 10 weeks before conception ("preconception"), and again, at 11(0/7) to 20(6/7) weeks' gestation ("in-pregnancy"). Excluded were women who died before birth, who had end-stage renal disease or kidney transplantation before conception, or whose pre-pregnancy SCr was 125 mu mol/L. Exposure: Net glomerular hyperfiltration defined as the preconception minus the in-pregnancy SCr. Measures: The primary study outcome was SMM or death arising from 23 weeks' gestation up to 42 days after the index birth. Methods: Adjusted relative risks (aRRs) were calculated using Modified Poisson regression per 1-SD net blunting of glomerular hyperfiltration adjusting for important covariates. Results: A total of 10,323 births met all inclusion criteria. The mean (SD) SCr was 61.7 (11.0) mu mol/L preconception, 48.0 (9.2) mu mol/L in-pregnancy, and the mean net difference 13.6 (8.2) mu mol/L. Among these births, the adjusted RR of SMM or death from 23 weeks' gestation up to 42 days post-partum was 1.16 (95% confidence interval 1.14-1.30) per 1-SD (8.2 mu mol/L) net blunting of glomerular hyperfiltration. Limitations: As SCr assessment is not a routine part of pregnancy care, its measurement could have been for a specific health condition thereby imparting selection bias. Conclusions: Blunted glomerular hyperfiltration in pregnancy may identify some women at higher risk of SMM. Further prospective research is needed about the implications of glomerular hyperfiltration in early pregnancy.
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Is there an association between glomerular hyperfiltration and coronary flow velocity reserve in patients with gestational diabetes history?
    Takir, Mumtaz
    Caklili, Ozge Telci
    Ozcan, Fatma Betul
    Atici, Adem
    Caliskan, Mustafa
    BIOMOLECULES AND BIOMEDICINE, 2024,
  • [22] Association between visceral adipose tissue and glomerular hyperfiltration in adolescents: A cross-sectional study
    Yang, Yong-Chang
    Zhao, Jing-Ying
    Zhao, Cheng-Guang
    ARCHIVES DE PEDIATRIE, 2025, 32 (01): : 24 - 29
  • [23] Post-Traumatic Stress Disorder and severe maternal morbidity: is there an association?
    Angelini, Carina R.
    Pacagnella, Rodolfo C.
    Parpinelli, Mary A.
    Silveira, Carla
    Andreucci, Carla B.
    Ferreira, Elton C.
    Santos, Juliana P.
    Zanardi, Dulce M.
    Souza, Renato T.
    Cecatti, Jose G.
    CLINICS, 2018, 73
  • [24] Weight gain during pregnancy and the risk of severe maternal morbidity by prepregnancy BMI
    Leonard, Stephanie A.
    Abrams, Barbara
    Main, Elliott K.
    Lyell, Deirdre J.
    Carmichael, Suzan L.
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2020, 111 (04) : 845 - 853
  • [25] Pregnancy as a Sentinel Event Preventing Severe Maternal Morbidity in Heart Transplant Recipients
    DeFilippis, Ersilia M.
    Kittleson, Michelle M.
    JACC-HEART FAILURE, 2023, 11 (12) : 1675 - 1677
  • [26] Antihypertensive Medication Use before and during Pregnancy and the Risk of Severe Maternal Morbidity in Individuals with Prepregnancy Hypertension
    Bane, Shalmali
    Wall-Wieler, Elizabeth
    Druzin, Maurice L.
    Carmichael, Suzan L.
    AMERICAN JOURNAL OF PERINATOLOGY, 2024, 41 : e728 - e738
  • [27] Prediction model for severe maternal morbidity in pregnant women with hypertensive disorders of pregnancy
    Bian, Yan
    Zheng, Shuisen
    Liu, Xiuwu
    Jiang, Xiuming
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2024, 40 (06) : 1054 - 1062
  • [28] Association Between Severe Maternal Morbidity and Psychiatric Illness Within 1 Year of Hospital Discharge After Delivery
    Lewkowitz, Adam K.
    Rosenbloom, Joshua I.
    Keller, Matt
    Lopez, Julia D.
    Macones, George A.
    Olsen, Margaret A.
    Cahill, Alison G.
    OBSTETRICS AND GYNECOLOGY, 2019, 134 (04) : 695 - 707
  • [29] Associations between maternal obesity and severe maternal morbidity: Findings from the French EPIMOMS population-based study
    Siddiqui, Ayesha
    Azria, Elie
    Howell, Elizabeth A.
    Deneux-Tharaux, Catherine
    Langer, Bruno
    Dupont, Corinne
    Rudigoz, Rene-Charles
    Vendittelli, Francoise
    Beucher, Gael
    Rozenberg, Patrick
    Carbillon, Lionel
    Baunot, Nathalie
    Crenn-Hebert, Catherine
    Kayem, Gilles
    Fresson, Jeanne
    Mignon, Alexandre
    Touzet, Sandrine
    Bonnet, Marie-Pierre
    Bouvier-Colle, Marie-Helene
    Chantry, Anne Alice
    Chiesa-Dubruille, Coralie
    Seco, Aurelien
    PAEDIATRIC AND PERINATAL EPIDEMIOLOGY, 2019, 33 (01) : 7 - 16
  • [30] Insomnia during pregnancy and severe maternal morbidity in the united states: nationally representative data from 2006 to 2017
    Kendle, Anthony M.
    Salemi, Jason L.
    Jackson, Chandra L.
    Buysse, Daniel J.
    Louis, Judette M.
    SLEEP, 2022, 45 (10)